All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

55

Reset

55 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • PovorcitinibINCB054707, INCB54707Phase 312 trials

    Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis

  • CM512Phase 39 trials

    Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma

  • LP-003SinglePhase 39 trials

    Longbio Pharma · Allergic Asthma, Chronic Spontaneous Urticaria (CSU), Peanut Allergies

  • LunsekimigSAR443765Phase 39 trials

    Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • GSK5784283Phase 38 trials

    GSK · Pulmonary Disease, Chronic Obstructive, Asthma, Nasal Polyps

  • PF-07275315tilrekimigPhase 38 trials

    Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease

  • MG-K10Humanized Monoclonal AntibodyPhase 36 trials

    Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis

  • SHR-1905Phase 36 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis

  • TozorakimabMEDI3506Phase 36 trials

    AstraZeneca · Chronic Obstructive Pulmonary Disease (COPD), Asthma, Viral Lung Infection and Acute Respiratory Failure

  • CM310Phase 35 trials

    Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease

  • JYB1904RPT904, ozureprubartPhase 35 trials

    Jemincare · Chronic Spontaneous Urticaria, Perennial Allergic Rhinitis, Immune System Diseases

  • TQC2731Phase 35 trials

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

  • BFFBFF MDI 320, BFF MDI 160Phase 34 trials

    AstraZeneca · Asthma

  • BGF MDI 320BGFPhase 33 trials

    AstraZeneca · Asthma, COPD (Chronic Obstructive Pulmonary Disease)

  • CM326Phase 33 trials

    CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. · Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps, Moderate to Severe Asthma

  • HSK31858Phase 33 trials

    Haisco Pharmaceutical Group Co., Ltd. · Non-cystic Fibrosis Bronchiectasis, Asthma Bronchiale, Bronchiectasis

  • 000 MG01Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • 000 MM09Phase 32 trials

    Inmunotek S.L. · Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic

  • BD MDIPhase 32 trials

    AstraZeneca · Asthma

  • Areteia Therapeutics · Chronic Obstructive Pulmonary Disease, Eosinophilic Asthma, Asthma; Eosinophilic

  • EP-088_MM09Phase 32 trials

    Inmunotek S.L. · Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma

  • GB-0895Phase 32 trials

    Generate Biomedicines · Severe Asthma

  • HFA-134aPhase 32 trials

    GSK · Asthma

  • HFA-152aPhase 32 trials

    GSK · Asthma

  • pMDI HFA-152aCHF5993 100, CHF5993 200Phase 32 trials

    Chiesi Farmaceutici S.p.A. · Asthma

  • SHR-1703Phase 32 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Eosinophilic Granulomatosis With Polyangiitis, Eosinophilic Asthma Patients

  • HR-1703Phase 31 trial

    Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma With Eosinophilic Phenotype

  • QMF149Phase 31 trial

    Novartis · Asthma

  • QVM149Phase 31 trial

    Novartis · Asthma

  • TEV-56248Phase 31 trial

    Teva · Asthma

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • VerekitugUPB-101Phase 24 trials

    Upstream Bio Inc. · Severe Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps

  • ENV-294Phase 23 trials

    Enveda Therapeutics · Atopic Dermatitis (AD), Atopic Dermatitis, Asthma

  • KT-621Phase 23 trials

    Kymera Therapeutics, Inc. · Eosinophilic Asthma, Atopic Dermatitis, Asthma (Diagnosis)

  • AD17002LThPhase 22 trials

    Advagene Biopharma Co. Ltd. · Eosinophilic Asthma

  • ARO-RAGEPhase 22 trials

    Arrowhead Pharmaceuticals · Asthma

  • FB825Phase 22 trials

    Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis

  • HB0056Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Asthma, Idiopathic Pulmonary Fibrosis (IPF)

  • JNJ-95597528Phase 22 trials

    Johnson & Johnson (Janssen) · Dermatitis, Atopic, Asthma

  • LondamocitinibAZD4604Phase 22 trials

    AstraZeneca · Asthma

  • PA9159 Metered-DosePhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • per day for 28 daysPhase 22 trials

    Anhui Palo Alto Pharmaceuticals, Inc. · Bronchial Asthma

  • PRA-216Phase 22 trials

    Prana Therapies Inc · Chronic Obstructive Pulmonary Disease (COPD), Mild to Moderate Asthma

  • RC1416Phase 22 trials

    Nanjing RegeneCore Biotech Co., Ltd. · Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Moderate to Severe Asthma

  • WIN378Phase 22 trials

    Windward Bio · COPD (Chronic Obstructive Pulmonary Disease), Asthma

  • AZD8630Phase 21 trial

    AstraZeneca · Asthma

  • CHF 6001Phase 21 trial

    Chiesi Farmaceutici S.p.A. · Asthma

  • ETH47Phase 21 trial

    Ethris GmbH · Asthma (Diagnosis)

  • FB704APhase 21 trial

    Oneness Biotech Co., Ltd. · Severe Asthma

  • FrevecitinibPhase 21 trial

    Kinaset Therapeutics Inc · Severe Asthma

Page 1 of 2Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.